Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc. announced FDA approval for its generic LURASIDONE HYDROCHLORIDE tablets, expanding the suppl...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
SUN PHARM has successfully secured FDA approval for NDA212595, unlocking its potential revenue stream from this strategic pharmaceutical product. This...
# FDA Approves Celgene's INREBIC (Fedratinib) for Myelofibrosis Treatment Celgene Corporation has received FDA approval for INREBIC (fedratinib hydro...
AbbVie Inc. received final regulatory approval on August 16, 2019, for Upadacitinib, expanding its gastrointestinal pharmacopoeia under the RINVOQ bra...
# FDA Approves Unichem Pharmaceuticals' Generic Tramadol Hydrochloride Unichem Pharmaceuticals (USA), Inc. received FDA approval for its generic tram...
# FDA Approves Generic Celecoxib Application for AiPing Pharmaceutical The FDA has approved ANDA208856 for AiPing Pharmaceutical, Inc.'s generic cele...
# FDA Approves New Generic Drug Application for Hibrow Healthcare Hibrow Healthcare has received FDA approval for its abbreviated new drug applicatio...
On July 30, 2019, the FDA granted approval for BAYER HEALTHCARE's generic drug NDA212099, a move that is expected to provide cost-effective competitio...
Cordavis Limited announced the FDA approval of adalimumab-bwwd, a biosimilar of a major TNF-alpha inhibitor, allowing for the establishment of a new m...
Pfizer Inc. received FDA approval for BMS-986165 on July 23, 2019, advancing its potential treatment for metabolic diseases. Market analysts anticipat...
Upsher-Smith Laboratories, LLC announced the approval of a supplemental New Drug Application for its Morphine Sulfate product, broadening its portfoli...
Leading Pharma, LLC received FDA approval for its Fenofibric Acid via ANDA211626, a strategic development that will likely expand generic availability...
# FDA Approves Karyopharm Therapeutics' XPOVIO (selinexor) for Multiple Myeloma Karyopharm Therapeutics Inc. received FDA approval for XPOVIO (seline...
Advagen Pharma Limited has gained FDA approval for its oral Tramadol Hydrochloride tablets, granting the company entry into the generic market for a w...
Eywa Pharma Inc. received 180-day exclusivity for the ANDA211610 approval of acetaminophen and codeine phosphate oral dosage form on June 27, 2019, si...
Cosette Pharmaceuticals received FDA approval for VYLEESI (bremelanotide acetate) on June 21, 2019, making it the first and only prescription therapy ...
Mylan received FDA approval on June 19, 2019, for the generic transdermal formulation of scopolamine, signaling a significant opportunity for market e...
# FDA Approves Genentech's POLIVY (polatuzumab vedotin) for Intravenous Administration Genentech's FDA approval of POLIVY (polatuzumab vedotin) marks...
Alembic Pharmaceuticals Limited announced the approval of its Abbreviated New Drug Application for Carbidopa and Levodopa, signaling a strategic expan...
Publix Super Markets Inc’s FDA approval of its diclofenac sodium topical preparation on May 16, 2019, further expands the generic threat to big-name b...